Related Experiment Videos
Sentinel lymph node biopsy in colorectal cancer: a pilot study
Heriberto Medina-Franco1, Takeshi Takahashi, Gabriel F González-Ruiz
1Division of Surgery, Section of Surgical Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City. herimd@hotmail.com
Summary
Sentinel lymph node biopsy (SLNB) is a feasible and safe technique for colorectal cancer management. This study demonstrates high diagnostic accuracy for SLNB in identifying metastatic colorectal cancer.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Sentinel lymph node biopsy (SLNB) is established in melanoma and breast cancer.
- Its application in colorectal cancer (CRC) remains debated.
- This study assesses SLNB feasibility and safety in CRC.
Purpose of the Study:
- To evaluate the feasibility of sentinel node biopsy in colorectal carcinoma.
- To determine the safety and diagnostic accuracy of SLNB for colorectal cancer.
Main Methods:
- Patients with non-metastatic colorectal carcinoma underwent intraoperative isosulfan blue dye injection.
- Sentinel nodes were identified, dissected, and examined via routine pathology and immunohistochemistry.
- Sensitivity and negative predictive value were calculated; adverse effects were recorded.
Main Results:
- Ten patients were included, with sentinel nodes identified in all.
- Mean sentinel lymph node count was 2.5 (vs. 15.6 non-sentinel nodes).
- SLNB demonstrated 100% sensitivity and negative predictive value post-immunohistochemistry, with no adverse dye reactions.
Conclusions:
- Sentinel lymph node biopsy is a feasible technique for colorectal cancer.
- SLNB offers high diagnostic accuracy and is safe for patients with colorectal cancer.
- This supports SLNB as a potential alternative to conventional lymphadenectomy in CRC.